C E Bayliss

1.2k total citations
13 papers, 842 citations indexed

About

C E Bayliss is a scholar working on Molecular Biology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, C E Bayliss has authored 13 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in C E Bayliss's work include Gastrointestinal motility and disorders (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Biomedical Ethics and Regulation (1 paper). C E Bayliss is often cited by papers focused on Gastrointestinal motility and disorders (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Biomedical Ethics and Regulation (1 paper). C E Bayliss collaborates with scholars based in Australia, United Kingdom and Canada. C E Bayliss's co-authors include R L Van, Daniel A. K. Roncari, Donald S. Beanlands, Ronald J. Baird, William E. Davies, P. Licina, Peter A. Silburn, François Féron, Patricia Fronek and Colin M. Gray and has published in prestigious journals such as Journal of Clinical Investigation, Brain and Annals of the Rheumatic Diseases.

In The Last Decade

C E Bayliss

13 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C E Bayliss Australia 10 236 190 180 174 144 13 842
Anthony C. Breuer United States 15 136 0.6× 99 0.5× 261 1.4× 69 0.4× 140 1.0× 21 823
Francesco Meli Italy 18 80 0.3× 166 0.9× 172 1.0× 73 0.4× 99 0.7× 46 836
Fumiharu Kimura Japan 17 146 0.6× 167 0.9× 101 0.6× 192 1.1× 176 1.2× 65 923
C B Shields United States 10 89 0.4× 92 0.5× 100 0.6× 64 0.4× 117 0.8× 14 538
Anahid Safari Iran 18 99 0.4× 114 0.6× 83 0.5× 63 0.4× 127 0.9× 53 813
Peter Ghenev Bulgaria 12 176 0.7× 96 0.5× 152 0.8× 38 0.2× 185 1.3× 60 858
E. Peter Bosch United States 19 298 1.3× 54 0.3× 328 1.8× 109 0.6× 222 1.5× 35 1.2k
James Hong Canada 18 146 0.6× 77 0.4× 242 1.3× 322 1.9× 268 1.9× 42 897
N. de Tribolet Switzerland 18 158 0.7× 77 0.4× 346 1.9× 191 1.1× 113 0.8× 41 1.0k
B. Cuevas Spain 13 152 0.6× 105 0.6× 159 0.9× 28 0.2× 169 1.2× 32 629

Countries citing papers authored by C E Bayliss

Since Specialization
Citations

This map shows the geographic impact of C E Bayliss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C E Bayliss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C E Bayliss more than expected).

Fields of papers citing papers by C E Bayliss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C E Bayliss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C E Bayliss. The network helps show where C E Bayliss may publish in the future.

Co-authorship network of co-authors of C E Bayliss

This figure shows the co-authorship network connecting the top 25 collaborators of C E Bayliss. A scholar is included among the top collaborators of C E Bayliss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C E Bayliss. C E Bayliss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Bayliss, C E, Simon Bond, Francis Dowling, et al.. (2019). Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial. BMJ Open. 9(2). e023765–e023765. 32 indexed citations
3.
Mackay‐Sim, Alan, François Féron, J. Cochrane, et al.. (2008). Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain. 131(9). 2376–2386. 324 indexed citations
4.
Ahern, Michael, William Harrison, Peter Hollingsworth, et al.. (1991). A randomised double‐blind trial of cyclosporin and azathioprine in refractory rheumatoid arthritis. Australian and New Zealand Journal of Medicine. 21(6). 844–849. 24 indexed citations
5.
Bayliss, C E, Donald S. Beanlands, & Ronald J. Baird. (1990). The pacemaker-twiddler's syndrome: a new complication of implantable transvenous pacemakers.. PubMed. 99(8). 371–3. 150 indexed citations
6.
Wyatt, G. M., et al.. (1988). The faecal flora of two patients with food-related irritable bowel syndrome during challenge with symptom-provoking foods. Journal of Medical Microbiology. 26(4). 295–299. 30 indexed citations
7.
Carroll, Graeme J. & C E Bayliss. (1983). Treatment of the arthropathy of familial hypercholesterolaemia.. Annals of the Rheumatic Diseases. 42(2). 206–209. 7 indexed citations
8.
Carroll, Graeme J., et al.. (1981). The prevalence of Raynaud's syndrome in rheumatoid arthritis.. Annals of the Rheumatic Diseases. 40(6). 567–570. 13 indexed citations
9.
Van, R L, C E Bayliss, & Daniel A. K. Roncari. (1976). Cytological and enzymological characterization of adult human adipocyte precursors in culture.. Journal of Clinical Investigation. 58(3). 699–704. 214 indexed citations
10.
Sanderson, C., Richard E. Davis, & C E Bayliss. (1976). Serum pyridoxal in patients with rheumatoid arthritis.. Annals of the Rheumatic Diseases. 35(2). 177–180. 12 indexed citations
11.
Bayliss, C E, et al.. (1975). Laboratory diagnosis of rheumatoid arthritis. Prospective study of 85 patients.. Annals of the Rheumatic Diseases. 34(5). 395–402. 8 indexed citations
12.
Wilkinson, Robert H., et al.. (1967). The utilization of long nylon catheters for prolonged intravenous infusions.. PubMed. 96(2). 94–7. 4 indexed citations
13.
Bayliss, C E, et al.. (1959). Some aspects of colonic microbial activity in irritable bowel syndrome associated with food intolerance.. PubMed. 22(3). 959–63. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026